During the past decade, Schlosspark-Klinik conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 13 clinical trials were completed, i.e. on average, 108.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 7 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Schlosspark-Klinik" #1 sponsor was "Pfizer" with 7 trials, followed by "Galapagos NV" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "ImmuPharma" with 2 trials sponsored and "ACELYRIN Inc." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Schlosspark-Klinik" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator and "Schlossparkklinik" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Schlosspark-Klinik" are "Rheumatoid Arthritis" (14 trials), "Lupus Erythematosus, Systemic" (2 trials), "Psoriatic Arthritis" (2 trials), "Systemic Lupus Erythematosus" (2 trials) and "Arthritis, Psoriatic" (1 trials). Many other conditions were trialed in "Schlosspark-Klinik" in a lesser frequency.

Most popular intervention types in "Schlosspark-Klinik" are "Drug" (18 trials), "Biological" (6 trials), "Other" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Baricitinib" (3 trials), "Filgotinib" (2 trials), "GLPG0634" (2 trials) and "IPP-201101" (2 trials). Other intervention names were less common.

The vast majority of trials in "Schlosspark-Klinik" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Schlosspark-Klinik". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Schlosspark-Klinik, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Schlosspark-Klinik, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".

Schlosspark-Klinik has several departments that took part in Clinical trials: "Schlosspark Klinik; Abt. Rheumatologie" - 5 trials